Baidu
map

2019年CROI:异烟肼疗法可预防艾滋病毒感染孕妇的结核病

2019-03-11 不详 网络

根据2019年逆转录病毒和机会性感染会议(CROI)上的一项研究结果,异烟肼治疗似乎对已被诊断患有艾滋病的准妈妈的结核病预防是安全的。

根据2019年逆转录病毒和机会性感染会议(CROI)上的一项研究结果,异烟肼治疗似乎对已被诊断患有艾滋病的准妈妈的结核病预防是安全的。

约翰霍普金斯医学院医学博士Nicole Salazar-Austin表示:怀孕和艾滋病毒都会增加结核病的风险。即使我们考虑到其他因素导致更糟糕的结果,例如晚期艾滋病毒、高龄孕妇和怀孕期间体重增加较低,这些结果仍然适用Salazar-Austin博士及其同事从前瞻性真实世界Tshepiso研究(2011-2014)中提取患者,该研究评估了患有和未患有活动性肺结核的HIV孕妇的母婴结局,异烟肼预防疗法由产前和艾滋病诊所启动,而不是由该研究启动。

异烟肼对结核杆菌有强大的抑菌至杀菌作用,也作用于细胞内的杆菌;毒性小,易吸收,穿透性强,用于各种类型的结核病;单用容易产生抗药性,常与对氨基水杨酸盐或链霉素合用。


原始出处:

http://www.firstwordpharma.com/node/1628634#axzz5houfIuVA

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1948854, encodeId=4159194885476, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Mon Apr 01 15:16:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857767, encodeId=627f185e767e6, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Thu Aug 15 06:16:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254267, encodeId=9017125426ea0, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Mar 13 00:16:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340396, encodeId=33be1340396a2, content=<a href='/topic/show?id=dbc0498101f' target=_blank style='color:#2F92EE;'>#异烟肼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49810, encryptionId=dbc0498101f, topicName=异烟肼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Mar 13 00:16:00 CST 2019, time=2019-03-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1948854, encodeId=4159194885476, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Mon Apr 01 15:16:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857767, encodeId=627f185e767e6, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Thu Aug 15 06:16:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254267, encodeId=9017125426ea0, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Mar 13 00:16:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340396, encodeId=33be1340396a2, content=<a href='/topic/show?id=dbc0498101f' target=_blank style='color:#2F92EE;'>#异烟肼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49810, encryptionId=dbc0498101f, topicName=异烟肼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Mar 13 00:16:00 CST 2019, time=2019-03-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1948854, encodeId=4159194885476, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Mon Apr 01 15:16:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857767, encodeId=627f185e767e6, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Thu Aug 15 06:16:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254267, encodeId=9017125426ea0, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Mar 13 00:16:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340396, encodeId=33be1340396a2, content=<a href='/topic/show?id=dbc0498101f' target=_blank style='color:#2F92EE;'>#异烟肼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49810, encryptionId=dbc0498101f, topicName=异烟肼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Mar 13 00:16:00 CST 2019, time=2019-03-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1948854, encodeId=4159194885476, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Mon Apr 01 15:16:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857767, encodeId=627f185e767e6, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Thu Aug 15 06:16:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254267, encodeId=9017125426ea0, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Mar 13 00:16:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340396, encodeId=33be1340396a2, content=<a href='/topic/show?id=dbc0498101f' target=_blank style='color:#2F92EE;'>#异烟肼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49810, encryptionId=dbc0498101f, topicName=异烟肼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Mar 13 00:16:00 CST 2019, time=2019-03-13, status=1, ipAttribution=)]

相关资讯

NEJM:儿童潜伏性结核分枝杆菌治疗方案——利福平vs异烟肼

研究认为,对于儿童肺结核患者,利福平和异烟肼治疗方案安全性及疗效相近,但利福平方案的治疗依从性更佳

NEJM:成人治疗潜伏性结核选择4个月利福平还是9个月异烟肼?

由此可见,在预防活动性结核病方面,利福平治疗4个月的方案并不逊于异烟肼治疗9个月的方案,并且其具有更高的治疗完成率和更好的安全性。

Eur Respir J:利福喷汀加异烟肼治疗中国潜伏性结核感染老年患者的短程疗效

由此可见,由于不良反应的高发生率,老年人必须谨慎使用短期治疗方案。需要进一步的工作来评估年轻人LTBI的超短治疗方案。

NEJM:儿童服用利福平与异烟肼的安全性及副作用比较

由此可见,在18岁以下的儿童中,使用4个月利福平的治疗具有相似的安全性和疗效,但比异烟肼治疗9个月的依从性更好。

2018 美国CDC建议:每周1次异烟肼-利福喷丁疗法治疗潜伏结核分枝杆菌感染(更新)

2018年7月,美国疾病控制与预防中心(CDC)更新了每周1次异烟肼-利福喷丁疗法治疗潜伏结核分枝杆菌感染建议,本文是对2011年CDC短期异烟肼-利福喷治疗建议的更新。

J Antimicrob Chemother:利福平和异烟肼,空腹和非空腹服药影响疗效吗?

2019年2月,西班牙、英国和秘鲁学者发表在《J Antimicrob Chemother》的一项研究,考察了食物对利福平和异烟肼药物代谢动力学的个体内影响。

Baidu
map
Baidu
map
Baidu
map